3 unchanged sentences
Exhibit Description Form Date Number
+Added: 10.1 Employment Agreement, dated as of April 1, 2022, by and between NovoCure USA LLC and Todd Longsworth#
+Added: 8-K April 7, 2022 10.1
31.1 Certification of Principal Executive Officer Required Under Rule 13a-14(a) and 15d-14(a) of the Securities Exchange Act of 1934, as amended
11 unchanged sentences
* The certifications attached as Exhibits 32.1 and 32.2 that accompany this Quarterly Report on Form 10-Q are not deemed filed with the Securities and Exchange Commission and are not to be incorporated by reference into any filing of NovoCure Limited under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date of this Form 10-Q, irrespective of any general incorporation language contained in such filing.
+Added: # Compensation plans and arrangements for executive officers and others.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
NovoCure Limited
−Removed: October 28, 2021 /s/ Ashley Cordova
+Added: April 28, 2022 /s/ Ashley Cordova
Ashley Cordova
3 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.